We demonstrated that CRC PDXs and CRC cells show a wide range of sensitivity to FASN inhibition and that high levels of FASN expression are associated with increased sensitivity of cancer cells to TVB inhibitors in vitro. This evidence concerns the gene FASN and colorectal carcinoma.